Early-Stage Dissemination and Implementation Research in Communication Disorders (R21 Clinical Trial Optional)
This upcoming grant will fund early-stage research on how to better spread and implement evidence-based practices in hearing, balance, taste, smell, voice, speech, and language disorders.
Funder: National Institutes of Health
Due Dates: June 17, 2027 (Full application submission deadline)
Funding Amounts: Estimated total program funding: $1,000,000; R21 award mechanism; typical R21 awards are up to 2 years and $275,000 direct costs over the project period.
Summary: Supports early-stage dissemination and implementation (D&I) research in communication disorders within NIDCD mission areas to facilitate the adoption of evidence-based innovations.
Key Information: No foreign subawards/subcontracts allowed; see eligibility for updated NIH international collaboration policy.
Description
This funding opportunity, offered by the National Institute on Deafness and Other Communication Disorders (NIDCD) at NIH, supports early-stage dissemination and implementation (D&I) research in the mission areas of hearing, balance, taste, smell, voice, speech, and language. The goal is to accelerate the adoption and integration of evidence-based innovations (EBIs) into clinical practice and everyday life, addressing the persistent gap between research findings and real-world application. Projects should lay the groundwork for future, larger-scale D&I research (such as an R01) in these areas. The mechanism is the R21 Exploratory/Developmental Grant, encouraging innovative, high-risk/high-reward pilot studies and collaborative projects that combine expertise in D&I science and communication disorders.
